Cargando…
MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance
BACKGROUND: Despite present studies which suggested miR-133a as a promising biomarker for several cancers, there still exist no articles concerning the validated clinical significance of miR-133a in non-small cell lung cancer (NSCLC). Therefore, in this study, we targeted the correlation between miR...
Autores principales: | Lan, Dong, Zhang, Xin, He, Rongquan, Tang, Ruixue, Li, Ping, He, Qiancheng, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409717/ https://www.ncbi.nlm.nih.gov/pubmed/25903369 http://dx.doi.org/10.1186/s40001-015-0139-z |
Ejemplares similares
-
Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
por: Tang, Ruixue, et al.
Publicado: (2015) -
Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues
por: Rong, Minhua, et al.
Publicado: (2014) -
The Clinicopathological Significance of miR-133a in Colorectal Cancer
por: Wan, Timothy Ming-Hun, et al.
Publicado: (2014) -
Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues
por: Pan, Linjiang, et al.
Publicado: (2014) -
Role of miR-1 and miR-133a in myocardial ischemic postconditioning
por: He, Bin, et al.
Publicado: (2011)